Inhibrx Biosciences, Inc. ("Inhibrx" or the "Company") , a biopharmaceutical company with two programs in ongoing clinical trials, today announced it entered into a loan and security agreement (the ...
Of the 34,605,494 Class A Shares approved for purchase under Brookfield Asset Management’s prior normal course issuer bid that commenced on January 11, 2024 and will expire on January 10, 2025, ...
Global steel wire market was valued at US$ 86.02 billion in 2023 and is estimated to reach valuation of US$ 204.50 billion by 2032 at a robust CAGR of 10.81% during the forecast period 2024–2032. A ...